LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 186 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,567,000 | -1.2% | 80,000 | 0.0% | 0.48% | +10.4% |
| Q4 2015 | $8,674,000 | -10.8% | 80,000 | -29.5% | 0.43% | -23.2% |
| Q3 2015 | $9,721,000 | -15.1% | 113,500 | 0.0% | 0.56% | -8.9% |
| Q2 2015 | $11,452,000 | +30.9% | 113,500 | 0.0% | 0.62% | -5.9% |
| Q1 2015 | $8,752,000 | +9.9% | 113,500 | -24.2% | 0.66% | -24.2% |
| Q4 2014 | $7,966,000 | +13.2% | 149,700 | 0.0% | 0.87% | -11.5% |
| Q3 2014 | $7,034,000 | -24.6% | 149,700 | 0.0% | 0.98% | -22.6% |
| Q2 2014 | $9,325,000 | -6.3% | 149,700 | +1.2% | 1.27% | -17.9% |
| Q1 2014 | $9,948,000 | +40.7% | 147,900 | +10.0% | 1.54% | -29.1% |
| Q4 2013 | $7,069,000 | – | 134,400 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |